An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who’s been using Wegovy (a prescription weight-loss drug) wrote that when they increased their weekly dose from 0.25 mg to 0.5 mg, their hunger and “food noise” (mental focus on food, cravings, or stomach rumbling) actually got worse instead of better. They say the lower dose had calmed things down a bit, but after the higher dose and by the next day they felt hungrier than they had in weeks. Wegovy’s active ingredient is semaglutide. That’s a man-made version of a natural gut hormone that helps tell your brain you’re full, slows how fast your stomach empties, and reduces appetite. Doctors prescribe it in carefully stepped-up doses to help people lose weight and to reduce cravings. It’s not a stimulant; it works by nudging appetite signals rather than making you feel wired. This report is a single-person, anecdotal observation rather than a study. Clinical trials of semaglutide generally show reduced appetite and weight loss for many people, but individual responses vary. Side effects commonly reported in studies include nausea, stomach upset, and changes in appetite patterns—sometimes these occur soon after a dose change. It’s plausible that timing of the injection, how the person’s body responds that week, or a temporary side effect like nausea could alter how hunger feels. But from one post you can’t conclude that higher doses usually increase hunger. Why this matters: if you or someone you know is starting or increasing a medication like Wegovy, it’s useful to know that not everyone’s experience is a straight line toward less hunger. Dose changes can bring temporary shifts in how you feel, and these can affect eating behavior and mood. People who rely on predictable appetite control for weight goals, or who struggle with disordered eating, should pay attention to these changes and discuss them with their clinician. Caveats and risks: this is just one person’s report, not proof of a general effect. Semaglutide is FDA-approved for certain uses at specific dosing schedules; self-adjusting doses or timing isn’t recommended. Common side effects include nausea, constipation, diarrhea, and abdominal pain; rare but serious risks include pancreatitis and gallbladder issues. If a dose increase causes worrying symptoms, unusual hunger patterns, or anything that affects safety, contact the prescribing provider rather than stopping or changing the medication on your own. Bottom line: some people may notice odd or temporary changes in hunger after a dose increase of Wegovy, but a single report doesn’t mean higher doses make most people hungrier—talk to your prescriber if it happens to you.
Source: r/Semaglutide